FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval of Drug Clinical Trial of a Subsidiary

Feb 27 05:37 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.

Feb 27 05:29 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Subsidiary

Feb 26 05:23 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application

Feb 26 05:19 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval for Drug Registration of a Licensed Product

Feb 26 05:10 ET

FOSUN PHARMA: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Feb 25 06:38 ET

FOSUN PHARMA: CONNECTED TRANSACTION - ENTERING INTO THE CAPITAL INCREASE AGREEMENT

Feb 20 06:57 ET

FOSUN PHARMA: Overseas regulatory announcement - An asset valuation report regarding the total equity value of the Shareholders of Shanghai Zhuoerhui General Outpatient Department Co., Ltd. in relation to the proposed capital increase of the company.

Feb 20 05:45 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.

Feb 20 05:39 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Regarding the announcement of capital increase and related Trade for the holding subsidiary.

Feb 20 05:34 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Release of Pledged Shares by Shareholders

Feb 20 05:29 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the pledge and release of a portion of the Shareholder's shares.

Feb 13 04:46 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Progress Announcement on Providing Guarantees for Holding Subsidiaries.

Feb 11 04:07 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Acceptance of a Subsidiary's Drug Registration Application

Feb 10 05:17 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the approval of clinical trials for the pharmaceutical by the USA FDA for the holding subsidiary.

Feb 10 05:10 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement in Relation to the Approval of Drug Clinical Trial of a Subsidiary

Feb 6 06:57 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Signing of a Licensing Agreement by a Wholly-Owned Subsidiary.

Feb 6 06:55 ET

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement regarding the Shareholder Holdings of the top ten shareholders and top ten unrestricted shareholders related to the A-share repurchase.

Feb 6 06:47 ET

FOSUN PHARMA: Overseas regulatory announcement - Announcement regarding the approval of the pharmaceutical of the holding subsidiary for listing in the EU.

Feb 5 06:22 ET

FOSUN PHARMA: NEXT DAY DISCLOSURE RETURN - SHARE BUYBACK

Feb 5 04:36 ET